Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Enovis Corporation ENOV
$56.07
+$0.28 (0.50%)
На 18:05, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
3060681768.00000000
-
week52high
68.15
-
week52low
43.88
-
Revenue
1563101000
-
P/E TTM
209
-
Beta
2.08754300
-
EPS
-0.71000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 12:30
Описание компании
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Evercore ISI Group | Outperform | 12 сент 2022 г. | |
| Canaccord Genuity | Buy | 12 сент 2022 г. | |
| Argus Research | Hold | 28 июн 2022 г. | |
| Wells Fargo | Equal-Weight | 16 июн 2022 г. | |
| Keybanc | Sector Weight | Overweight | 21 апр 2022 г. |
| Wells Fargo | Equal-Weight | Equal-Weight | 26 окт 2022 г. |
| Jefferies | Buy | 12 окт 2022 г. | |
| Goldman Sachs | Buy | 11 окт 2022 г. | |
| Baird | Outperform | Outperform | 03 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| PERFALL A CLAYTON | A | 32033 | 444 | 30 дек 2022 г. |
| Wienbar Sharon L | A | 19789 | 421 | 30 дек 2022 г. |
| Lalor Angela S | A | 3070 | 327 | 30 дек 2022 г. |
| Hix Christopher M | D | 44605 | 1367 | 14 дек 2022 г. |
| PRYOR DANIEL A | D | 0 | 67421 | 15 ноя 2022 г. |
| PRYOR DANIEL A | D | 75731 | 67421 | 15 ноя 2022 г. |
| PRYOR DANIEL A | A | 143152 | 67421 | 15 ноя 2022 г. |
| PERFALL A CLAYTON | A | 31589 | 516 | 30 сент 2022 г. |
| Lalor Angela S | A | 2743 | 380 | 30 сент 2022 г. |
| Wienbar Sharon L | A | 19368 | 489 | 30 сент 2022 г. |
Новостная лента
Enovis Corporation (ENOV) Q3 2022 Earnings Call Transcript
Seeking Alpha
02 ноя 2022 г. в 12:25
Enovis Corporation (NYSE:ENOV ) Q3 2022 Earnings Conference Call November 2, 2022 8:00 AM ET Company Participants Derek Leckow - Vice President, Investor Relations Matt Trerotola - Chief Executive Officer Chris Hix - Executive Vice President & Chief Financial Officer Ben Berry - Interim Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Vik Chopra - Wells Fargo Matt Mishan - KeyBanc Xuyang Li - Jefferies Kyle Rose - Canaccord Operator Ladies and gentlemen, thank you for standing by, and welcome to the Enovis Third Quarter 2022 Earnings Call. I would now like to turn the call over to Derek Leckow, Vice President of Investor Relations.
Enovis (ENOV) Beats Q3 Earnings and Revenue Estimates
Zacks Investment Research
02 ноя 2022 г. в 09:03
Enovis (ENOV) delivered earnings and revenue surprises of 25.53% and 1.07%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Enovis to Participate in Investor Conferences in November
GlobeNewsWire
28 окт 2022 г. в 15:58
Wilmington, DE, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in two investor conferences in November.
Will Enovis (ENOV) Beat Estimates Again in Its Next Earnings Report?
Zacks Investment Research
26 окт 2022 г. в 13:33
Enovis (ENOV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Enovis to Host Third Quarter 2022 Conference Call on November 2nd
GlobeNewsWire
13 окт 2022 г. в 09:30
Wilmington, DE, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2022 financial results on Wednesday, November 2, 2022 at 8:00AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.